Atlas Trials

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

Clinical trial NCT00851565 · UNKNOWN

Trial details

NCT number
NCT00851565
Sponsor
Copenhagen University Hospital at Herlev
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2009-06-01
Primary completion
2012-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.